PMID:109187

Citation	Copeland, EM 3rd, Daly, JM, Ota, DM and Dudrick, SJ (1979) Nutrition, cancer, and intravenous hyperalimentation. Cancer 43:2108-16
Abstract	In over 1000 cancer patients treated with intravenous hyperalimentation (IVH), tumor growth has not been identified and catheter-related sepsis has been minimal. Studies in rats demonstrated that the host benefits more than the tumor during nutritional repletion, and any stimulation of tumor growth in the rat-tumor model could be manipulated with DNA specific drugs to benefit the host. A study of 65 malnourished cancer patients undergoing oncologic therapy and treated with IVH indicated that much of the immune suppression in these patients was the result of malnutrition coincident with or secondary to oncologic treatment. Conclusions reached in this study were that nutritional repletion resulted in a return of skin test reactivity, proper wound healing in the surgical patient, and possibly an increase in response to chemotherapy. Certainly, the use of IVH allowed specific oncologic therapy to be administered to a group of malnourished patients who otherwise might not have been acceptable candidates for intensive antineoplastic therapy.
Links	PubMed Online version:<2108::aid-cncr2820430720>3.0.co;2-6 10.1002/1097-0142(197905)43:5+<2108::aid-cncr2820430720>3.0.co;2-6
Keywords	Animals; Dietary Fats/administration & dosage; Humans; Immunosuppression; Neoplasms/complications; Neoplasms/diet therapy; Neoplasms/immunology; Nutrition Disorders/complications; Nutrition Disorders/diet therapy; Nutrition Disorders/immunology; Parenteral Nutrition/adverse effects; Parenteral Nutrition, Total/adverse effects; Sepsis/etiology; Skin Tests
edit table

Annotations

Gene product	Qualifier	GO Term	Evidence Code	with/from	Aspect	Extension	Notes	Status

References

See Help:References for how to manage references in GONUTS.